New study to explore impacts of COVID-19 on Australians who use illicit drugs
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impacts of COVID-19 on Australians who use illicit drugs.
Led by researchers from the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney, ADAPT is one of the first studies globally to talk with people who regularly use illicit drugs about their experiences during the COVID-19 pandemic.
The study comprises an online cross-sectional survey of people who were regularly using illicit drugs prior to the emergence of COVID-19, embedded within a longitudinal cohort who will complete six additional waves of surveys.
Recruitment is now open, and participants have the option to:
- Join the cohort (complete a confidential baseline survey and follow-up surveys in two months, four months, six months, 12 months, two years and three years)
- Take part in the confidential baseline survey only
Those who take part will have the opportunity to enter a prize draw to win one of 20 $100 Gift Pay vouchers.
The ADAPT Study will ensure drug-related issues during COVID-19 are better understood, accurately represented, and used to inform drug treatment and harm reduction in Australia.